ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $17,753,000 | +90.0% | 157,762 | +60.9% | 0.13% | +63.0% |
| Q2 2020 | $9,344,000 | +38.6% | 98,078 | +30.8% | 0.08% | +12.5% |
| Q1 2020 | $6,740,000 | -57.1% | 75,000 | -76.9% | 0.07% | -24.2% |
| Q2 2018 | $15,729,000 | -62.5% | 324,185 | -69.8% | 0.10% | -77.5% |
| Q1 2018 | $41,950,000 | -4.0% | 1,072,898 | +4.2% | 0.42% | -6.2% |
| Q4 2017 | $43,713,000 | +10.0% | 1,030,000 | -3.3% | 0.45% | +0.9% |
| Q3 2017 | $39,746,000 | +21.7% | 1,065,000 | -0.9% | 0.45% | +1.6% |
| Q2 2017 | $32,669,000 | +64.6% | 1,075,000 | +43.3% | 0.44% | +48.1% |
| Q1 2017 | $19,853,000 | +44.7% | 750,000 | +39.5% | 0.30% | +35.6% |
| Q4 2016 | $13,719,000 | +2464.3% | 537,588 | +3726.5% | 0.22% | +2090.0% |
| Q1 2015 | $535,000 | – | 14,049 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |